<DOC>
	<DOCNO>NCT00406783</DOCNO>
	<brief_summary>This study investigate effectiveness desloratadine treat subject allergic rhinitis ( AR ) meet criterion intermittent allergic rhinitis .</brief_summary>
	<brief_title>Study Treatment Intermittent Allergic Rhinitis With Desloratadine ( Study P04683 )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<mesh_term>Loratadine</mesh_term>
	<criteria>The subject must meet ALL criterion list entry : For study , diagnosis IAR base solely current episode AR . Subjects must least 2 year history AR consistent IAR ( define symptom allergic rhinitis present less four day per week le four consecutive week per year ) ; current episode count second year . Subjects must 12 year age old , either sex race . At RunIn Visit , subject must sufficiently symptomatic , T5SS 12hour AMPRIOR ( reflective ) symptom severity score least 6 . In order subject qualify Baseline Visit , sum daily average diary recording 12hour AM PRIOR + PMPRIOR ( reflective ) T5SS collect Days 4 1 AM PRIOR T5SS morning Baseline Visit ( Day 1 ) must &gt; = 30 . Subjects must positive skinprick test screen one allergens GA2LEN ( usually use local ) panel seasonal perennial allergen . Subjects must demonstrate antigeninduced skin prick wheal least 3 mm diameter great diluent control . The positive test must include allergen ( ) prevalent study active . Subjects must free clinically significant disease , IAR , would interfere study evaluation . Subjects , parents/legal guardian , must give write informed consent . Subjects must able adhere dose visit schedule meet study requirement . In female childbearing potential , urine pregnancy test ( hCG ) must negative Screening Visit . Nonsterile premenopausal female subject must use medically accept method birth control , , oral contraceptive , hormonal implant , medically prescribe intrauterine device ( IUD ) , depot injectable entire study . A female subject currently sexually active must agree consent use one abovementioned method , become sexually active participate study . A female subject childbearing potential must medical record surgically sterile ( example , hysterectomy tubal ligation ) , least 1 year postmenopausal . The subject exclude entry ANY criterion list meet : Subjects history anaphylaxis and/or severe local reaction ( ) skin test allergen . Subjects intolerable symptom would make participate study unbearable . Subjects upper respiratory tract sinus infection require antibiotic therapy , least 14day washout prior runin period , viral upper respiratory infection within 7 day prior screen . Subjects asthma require chronic use inhale systemic corticosteroid . Subjects current history frequent , clinically significant sinusitis chronic purulent postnasal drip . Subjects immunotherapy ( desensitization therapy ) unless regular maintenance schedule prior Visit 1 stay schedule remainder study . Subjects , opinion investigator , dependent nasal , oral ocular decongestant , nasal topical antihistamine nasal steroid . Subjects use drug device investigational protocol 30 day prior Visit 1 . Female subject pregnant nursing . Subjects history hypersensitivity study drug excipients know tolerate antihistamine . Subject member Investigational Study Staff ( currently involve study ) member staff 's family . Subjects current evidence clinically significant hematopoietic , cardiovascular , hepatic , renal , neurologic , psychiatric , autoimmune disease , diseases preclude subject 's participation study . Subjects whose ability provide inform consent compromise . Subjects history noncompliance medication treatment protocol . Subjects rhinitis medicamentosa . Subjects , opinion investigator designee , clinically significant nasal structural abnormality , include large nasal polyp mark septum deviation , significantly interfere nasal air flow . Subjects observed medication washout time outline protocol prior Visit 2 .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Allergic Rhinitis</keyword>
	<keyword>Intermittent Allergic Rhinitis</keyword>
</DOC>